참고문헌
- Avigad S, Barel D, Blau O, et al (1997). A novel germ line p53mutation in intron 6 in diverse childhood malignancies. Oncogene, 14, 1541-5. https://doi.org/10.1038/sj.onc.1200990
- Azzam GA, Frank AK, Hollstein M, Murphy ME (2011). Tissue-specific apoptotic effects of the p53 codon 72 polymophism in a mouse model. Cell Cycle, 10, 1352-5. https://doi.org/10.4161/cc.10.9.15344
- Beckman G, Birgander R, Sjalander A, et al (1994). Is p53polymorphism maintained by natural selection? Hum Hered, 44, 266-70. https://doi.org/10.1159/000154228
- Beenken SW, Karsenty G, Raycroft L, Lozano G (1991). An intron binding protein is required for transformation ability of p53. Nucleic Acids Res, 19, 4747-52. https://doi.org/10.1093/nar/19.17.4747
- Bergamaschi D, Gasco M, Hiller L, et al (2003). p53polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell, 3, 387-402. https://doi.org/10.1016/S1535-6108(03)00079-5
- Chakrabarti S, Dasgupta S, Roy S, et al (2001). Microsatellite instability in squamous cell carcinoma of head and neck from the Indian patient population. Int J Cancer, 92, 555-61. https://doi.org/10.1002/ijc.1233
- Chumakov PM, Jenkins JR (1991). BstNI/NciI polymorphism of the human p53 gene (TP53). Nucleic Acids Res, 19, 6969.
- Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M (2003). The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet, 33, 357-65. https://doi.org/10.1038/ng1093
- Felley-Bosco E, Weston A, Cawley HM, Bennett WP, Harris CC (1993). Functional studies of a germ-line polymorphism at codon 47 within the p53 gene. Am J Hum Genet, 53, 752-9.
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: Globocan 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Francisco G, Menezes PR, Eluf-Neto J, Chammas R (2011). Arg72Pro P53 polymorphism and cancer susceptibility: a comprehensive meta-analysis of 302 case-control studies. Int J Cancer, 129, 920-30. https://doi.org/10.1002/ijc.25710
- Frank AK, Leu JI, Zhou Y, et al (2011). The codon 72 polymorphism of p53 regulates interaction with NF-{kappa}B and transactivation of genes involved in immunity and inflammation. Mol Cell Biol, 31, 1201-13. https://doi.org/10.1128/MCB.01136-10
- Galli P, Cadoni G, Volante M, et al (2009). A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population. BMC Cancer, 9, 137. https://doi.org/10.1186/1471-2407-9-137
- Gemignani F, Moreno V, Landi S, et al (2004). A TP53polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene, 23, 1954-6. https://doi.org/10.1038/sj.onc.1207305
- Hrstka R, Beranek M, Klocova K, Nenutil R, Vojtesek B (2009). Intronic polymorphisms in TP53 indicate lymph node metastasis in breast cancer. Oncol Rep, 22, 1205-11.
- Hsieh LL, Huang TH, Chen IH, et al (2005). p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. Br J Cancer, 92, 30-5. https://doi.org/10.1038/sj.bjc.6602271
- Hu Z, Li C, Chen K, et al (2008). Single nucleotide polymorphisms in selected apoptotic genes and BPDE-induced apoptotic capacity in apparently normal primary lymphocytes: a genotype-phenotype correlation analysis. J Cancer Epidemiol, 2008, 147905.
- Hu Z, Li X, Qu X, et al (2010). Intron 3 16 bp duplication polymorphism of TP53 contributes to cancer susceptibility: a meta-analysis. Carcinogenesis, 31, 643-7. https://doi.org/10.1093/carcin/bgq018
- Imyanitov EN, Togo AV, Hanson KP (2004). Searching for cancer-associated gene polymorphisms: promises and obstacles. Cancer Lett, 204, 3-14. https://doi.org/10.1016/j.canlet.2003.09.026
- Katiyar S, Thelma BK, Murthy NS, et al (2003). Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem, 252, 117-24. https://doi.org/10.1023/A:1025546610920
- Khaliq S, Hameed A, Khaliq T, et al (2000). P53 mutations, polymorphisms, and haplotypes in Pakistani ethnic groups and breast cancer patients. Genet Test, 4, 23-9. https://doi.org/10.1089/109065700316435
- Kietthubthew S, Sriplung H, Au WW, Ishida T (2003). The p53Codon 72 polymorphism and risk of oral cancer in Southern Thailand. Asian Pac J Cancer Prev, 4, 209-14.
- Kuroda Y, Nakao H, Ikemura K, Katoh T (2007). Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol, 43, 1043-8. https://doi.org/10.1016/j.oraloncology.2006.12.001
- Lazar V, Hazard F, Bertin F, et al (1993). Simple sequence repeat polymorphism within the p53 gene. Oncogene, 8, 1703-5.
- Lehman TA, Haffty BG, Carbone CJ, et al (2000). Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res, 60, 1062-9.
- Lozano G, Levine AJ (1991). Tissue-specific expression of p53in transgenic mice is regulated by intron sequences. Mol Carcinog, 4, 3-9. https://doi.org/10.1002/mc.2940040103
- Matlashewski GJ, Tuck S, Pim D, et al (1987). Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol, 7, 961-3.
- Mattick JS (1994). Introns: evolution and function. Curr Opin Genet Dev, 4, 823-31. https://doi.org/10.1016/0959-437X(94)90066-3
- Mitra S, Chatterjee S, Panda CK, et al (2003). Haplotype structure of TP53 locus in Indian population and possible association with head and neck cancer. Ann Hum Genet, 67, 26-34. https://doi.org/10.1046/j.1469-1809.2003.00005.x
- Mitra S, Sikdar N, Misra C, et al (2005). Risk assessment of p53genotypes and haplotypes in tobacco-associated leukoplakia and oral cancer patients from eastern India. Int J Cancer, 117, 786-93. https://doi.org/10.1002/ijc.21263
- Mittal RD, George GP, Mishra J, Mittal T, Kapoor R (2011). Role of functional polymorphisms of p53 and p73 genes with the risk of prostate cancer in a case-control study from Northern India. Arch Med Res, 42, 122-7. https://doi.org/10.1016/j.arcmed.2011.03.001
- Nagpal JK, Patnaik S, Das BR (2002). Prevalence of high-risk human papilloma virus types and its association with p53codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer, 97, 649-53. https://doi.org/10.1002/ijc.10112
- Ozeki C, Sawai Y, Shibata T, et al (2011). Cancer susceptibility polymorphism of p53 at codon 72 affects phosphorylation and degradation of p53 protein. J Biol Chem, 286, 18251-60. https://doi.org/10.1074/jbc.M110.208587
- Pandith AA, Shah ZA, Khan NP, et al (2010). Role of TP53Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population. Cancer Genet Cytogenet, 203, 263-8. https://doi.org/10.1016/j.cancergencyto.2010.08.010
- Paterson IC, Eveson JW, Prime SS (1996). Molecular changes in oral cancer may reflect aetiology and ethnic origin. Eur J Cancer B Oral Oncol, 32, 150-3. https://doi.org/10.1016/0964-1955(95)00065-8
- Pim D, Banks L (2004). p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer, 108, 196-9. https://doi.org/10.1002/ijc.11548
- Saini R, Tang TH, Zain RB, et al (2011). Significant association of high-risk human papillomavirus (HPV) but not of p53polymorphisms with oral squamous cell carcinomas in Malaysia. J Cancer Res Clin Oncol, 137, 311-20. https://doi.org/10.1007/s00432-010-0886-8
- Sameer S, Shah ZA, Syeed N, et al (2010). TP53 Pro47Ser and Arg72Pro polymorphisms and colorectal cancer predispostion in an ethinic Kashmiri population. Genet Mol Res, 9, 651-60. https://doi.org/10.4238/vol9-2gmr751
- Schneider-Stock R, Mawrin C, Motsch C, et al (2004). Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol, 164, 1233-41. https://doi.org/10.1016/S0002-9440(10)63211-7
- Shamsher M, Montano X (1996). Analysis of intron 4 of the p53gene in human cutaneous melanoma. Gene, 176, 259-62. https://doi.org/10.1016/0378-1119(96)00000-5
- Sprague BL, Trentham-Dietz A, Garcia-Closas M, et al (2007). Genetic variation in TP53 and risk of breast cancer in a population-based case control study. Carcinogenesis, 28, 1680-6. https://doi.org/10.1093/carcin/bgm097
- Stephens M, Smith NJ, Donnelly P (2001). A new statistical method for haplotype reconstruction from population data. Am J Hum Genet, 68, 978-89. https://doi.org/10.1086/319501
- Storey A, Thomas M, Kalita A, et al (1998). Role of a p53polymorphism in the development of human papillomavirus-associated cancer. Nature, 393, 229-34. https://doi.org/10.1038/30400
- Suresh K, Chandiraasekar R, Kumar BL, Venkatesan R, Sasikala K (2010). No association between the TP53 codon 72 polymorphism and Head and Neck Cancer: A case-control study in a south Indian population. Asian Pac J Cancer Prev, 11, 1749-53.
- Suresh K, Venkatesan R, Chandirasekar R, Kumar BL, Sasikala K (2011). Association of TP53 Arg72Pro polymorphic variants with breast cancer - a case control study in south Indian population. Biology and Medicine, 3, 15-22.
- Tandle AT, Sanghvi V, Saranath D (2001). Determination of p53genotypes in oral cancer patients from India. Br J Cancer, 84, 739-42. https://doi.org/10.1054/bjoc.2000.1674
- Thomas M, Kalita A, Labrecque S, et al (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 19, 1092-100.
- Wang-Gohrke S, Weikel W, Risch H, et al (1999). Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations. Br J Cancer, 81, 179-83. https://doi.org/10.1038/sj.bjc.6690669
- Weston A, Wolff MS, Morabia A, et al (1998). True extended haplotypes of p53: indicators of breast cancer risk. Cancer Genet Cytogenet, 102, 153-4. https://doi.org/10.1016/S0165-4608(97)00349-X
- Whibley C, Pharoah PD, Hollstein M (2009). p53 polymorphisms: cancer implications. Nat Rev Cancer, 9, 95-107. https://doi.org/10.1038/nrc2584
- Wu X, Zhao H, Amos CI, et al (2002). p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst, 94, 681-90. https://doi.org/10.1093/jnci/94.9.681
- Zhu F, Dolle ME, Berton TR, et al (2010). Mouse models for the p53 R72P polymorphism mimic human phenotypes. Cancer Res, 70, 5851-9. https://doi.org/10.1158/0008-5472.CAN-09-4646
- Zhuo XL, Li Q, Zhou Y, et al (2009). Study on TP53 codon 72 polymorphisms with oral carcinoma susceptibility. Arch Med Res, 40, 625-34. https://doi.org/10.1016/j.arcmed.2009.09.004
피인용 문헌
- Association of a p53 Codon 72 Gene Polymorphism with Environmental Factors and Risk of Lung Cancer: a Case Control Study in Mizoram and Manipur, a High Incidence Region in North East India vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10653
- P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility vol.16, pp.1, 2015, https://doi.org/10.1186/s12863-015-0235-7
- Association of P53 (−16ins-Pro) Haplotype with the Decreased Risk of Differentiated Thyroid Carcinoma in Iranian-Azeri Patients vol.21, pp.2, 2015, https://doi.org/10.1007/s12253-014-9846-y
- p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence vol.17, pp.3, 2016, https://doi.org/10.7314/APJCP.2016.17.3.1243
- Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients vol.39, pp.5, 2017, https://doi.org/10.1177/1010428317699113
- Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis vol.18, pp.1, 2018, https://doi.org/10.1186/s12903-018-0603-6
- Meta-Analysis Results on the Association Between TP53 Codon 72 Polymorphism With the Susceptibility to Oral Cancer vol.9, pp.1664-042X, 2018, https://doi.org/10.3389/fphys.2018.01014
- Salivary protease spectrum biomarkers of oral cancer vol.11, pp.1, 2019, https://doi.org/10.1038/s41368-018-0032-z